Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.
2.

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.

MacDiarmid JA, Langova V, Bailey D, Pattison ST, Pattison SL, Christensen N, Armstrong LR, Brahmbhatt VN, Smolarczyk K, Harrison MT, Costa M, Mugridge NB, Sedliarou I, Grimes NA, Kiss DL, Stillman B, Hann CL, Gallia GL, Graham RM, Brahmbhatt H.

PLoS One. 2016 Apr 6;11(4):e0151832. doi: 10.1371/journal.pone.0151832. eCollection 2016.

3.

NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?

Friberg S, Nyström AM.

J Nanobiotechnology. 2016 Mar 9;14:17. doi: 10.1186/s12951-016-0172-2.

4.

Improving Nanoparticle Penetration in Tumors by Vascular Disruption with Acoustic Droplet Vaporization.

Ho YJ, Chang YC, Yeh CK.

Theranostics. 2016 Jan 6;6(3):392-403. doi: 10.7150/thno.13727. eCollection 2016.

5.

Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.

Li Y, Lian Y, Zhang LT, Aldousari SM, Hedia HS, Asiri SA, Liu WK.

Interface Focus. 2016 Feb 6;6(1):20150086. doi: 10.1098/rsfs.2015.0086.

PMID:
26855759
6.

Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.

Pillai G, Ceballos-Coronel ML.

SAGE Open Med. 2013 Nov 23;1:2050312113513759. doi: 10.1177/2050312113513759. eCollection 2013.

7.

Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.

Gao S, Li J, Jiang C, Hong B, Hao B.

Drug Des Devel Ther. 2015 Dec 17;10:1-11. doi: 10.2147/DDDT.S95843. eCollection 2016.

8.

Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ.

Nanomedicine. 2016 Feb;12(2):269-86. doi: 10.1016/j.nano.2015.10.020. Epub 2015 Dec 17. Review.

PMID:
26707818
9.

Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.

Han B, Qu C, Park K, Konieczny SF, Korc M.

Cancer Lett. 2015 Dec 10. pii: S0304-3835(15)00739-9. doi: 10.1016/j.canlet.2015.12.003. [Epub ahead of print]

PMID:
26688098
10.

Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Au JL, Yeung BZ, Wientjes MG, Lu Z, Wientjes MG.

Adv Drug Deliv Rev. 2016 Feb 1;97:280-301. doi: 10.1016/j.addr.2015.12.002. Epub 2015 Dec 11. Review.

PMID:
26686425
11.

A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells.

Solomon BJ, Desai J, Rosenthal M, McArthur GA, Pattison ST, Pattison SL, MacDiarmid J, Brahmbhatt H, Scott AM.

PLoS One. 2015 Dec 11;10(12):e0144559. doi: 10.1371/journal.pone.0144559. eCollection 2015.

12.

Brain tumor-targeted drug delivery strategies.

Wei X, Chen X, Ying M, Lu W.

Acta Pharm Sin B. 2014 Jun;4(3):193-201. doi: 10.1016/j.apsb.2014.03.001. Epub 2014 Apr 5. Review.

13.

Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery.

Tian X, Lara H, Wagner KT, Saripalli S, Hyder SN, Foote M, Sethi M, Wang E, Caster JM, Zhang L, Wang AZ.

Nanoscale. 2015 Dec 21;7(47):20211-9. doi: 10.1039/c5nr05869d. Epub 2015 Nov 17.

PMID:
26575637
14.

Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy.

Gkretsi V, Stylianou A, Papageorgis P, Polydorou C, Stylianopoulos T.

Front Oncol. 2015 Oct 14;5:214. doi: 10.3389/fonc.2015.00214. eCollection 2015. Review.

15.

Comparative effect of gold nanorods and nanocages for prostate tumor hyperthermia.

Robinson R, Gerlach W, Ghandehari H.

J Control Release. 2015 Dec 28;220(Pt A):245-52. doi: 10.1016/j.jconrel.2015.10.036. Epub 2015 Oct 23.

PMID:
26526969
16.

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Suk JS, Xu Q, Kim N, Hanes J, Ensign LM.

Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):28-51. doi: 10.1016/j.addr.2015.09.012. Epub 2015 Oct 9. Review.

PMID:
26456916
17.

Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue.

Saucier-Sawyer JK, Deng Y, Seo YE, Cheng CJ, Zhang J, Quijano E, Saltzman WM.

J Drug Target. 2015;23(7-8):736-49. doi: 10.3109/1061186X.2015.1065833.

18.

Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.

Lin YL, Chang KF, Huang XF, Hung CL, Chen SC, Chao WR, Liao KW, Tsai NM.

Int J Nanomedicine. 2015 Sep 28;10:6009-20. doi: 10.2147/IJN.S85790. eCollection 2015.

19.

Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma.

Seo JW, Ang J, Mahakian LM, Tam S, Fite B, Ingham ES, Beyer J, Forsayeth J, Bankiewicz KS, Xu T, Ferrara KW.

J Control Release. 2015 Dec 28;220(Pt A):51-60. doi: 10.1016/j.jconrel.2015.09.057. Epub 2015 Oct 5.

PMID:
26437259
20.

Cubical Shape Enhances the Interaction of Layer-by-Layer Polymeric Particles with Breast Cancer Cells.

Alexander JF, Kozlovskaya V, Chen J, Kuncewicz T, Kharlampieva E, Godin B.

Adv Healthc Mater. 2015 Dec 9;4(17):2657-66. doi: 10.1002/adhm.201500537. Epub 2015 Oct 1.

PMID:
26424126
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk